MétaCan
Menu
← Back to cohort

P2887Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry

2018· article· en· W2889216992 on OpenAlexaff
Sérgio Dubner, Menno V. Huisman, Hans‐Christoph Diener, Jonathan L. Halperin, Kenneth J. Rothman, Sara Bozzinì, Jutta Bergler‐Klein, Kristina Zint, Lionel Riou França, Shihai Lu, Christine Teutsch, Miney Paquette, Gregory Y.H. Lip

Bibliographic record

VenueEuropean Heart Journal · 2018
Typearticle
Languageen
FieldMedicine
TopicAtrial Fibrillation Management and Outcomes
Canadian institutionsBoehringer Ingelheim (Canada)
FundersMedizinische Universität WienDaiichi-SankyoUniversity of BirminghamDaiichi Sankyo EuropeBoehringer Ingelheim
KeywordsMedicineDabigatranAtrial fibrillationHeart failureInternal medicineCardiologyIntensive care medicineWarfarin

Abstract

fetched live from OpenAlex

Background: Heart failure (HF) and atrial fibrillation (AF) are common cardiovascular conditions that are independently associated with poor outcomes but often occur concurrently. Co-diagnosis confers increased risks of thromboembolic events that are more than additive. Objectives: To describe baseline characteristics and 2-year outcomes in AF patients with and without HF who were treated with dabigatran etexilate (DE) in a prospective, global registry program (GLORIA-AF). Methods: Newly diagnosed non-valvular AF (NVAF) patients with a CHA2DS2-VASc score ≥1 were consecutively enrolled. Baseline characteristics of the total group and clinical outcomes in patients prescribed DE were assessed according to presence or absence of HF at time of enrollment. Results: A total of 15,308 patients were enrolled, including 3679 (24.0%) with HF, 11,475 (75.0%) without HF, and 154 (1.0%) with HF status unknown. Patients with HF were more often male (60.9%), and had higher rates of prior myocardial infarction (18.8% vs. 7.8%), coronary artery disease (31.6% vs. 16.7%), and greater proportions of symptomatic (39.5% vs. 24.6%) and permanent AF (15.2% vs. 9.7%) compared to patients without HF. Of 4873 patients prescribed DE, 1169 (24.0%) patients had prior HF, 3658 (75.1%) no prior HF, and 46 patients (0.9%) uncertain. Stroke risk was high (CHA2DS2-VASc score ≥2) in 94.3% with HF and 85.8% of patients without HF, while 6% of patients with HF versus 7% without HF had known high risk of bleed (HAS-BLED ≥3). Clinical characteristics of the patients prescribed DE showed differences for the same variables noted in the overall group between patients with and without HF. Crude incidence rates for outcomes are presented in the table. Incidence rates standardized by stroke and bleeding risk will be presented.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.012

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.048
GPT teacher head0.323
Teacher spread0.275 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Heart Journal→Same topicAtrial Fibrillation Management and Outcomes→French-language works237,207→